Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
DARE
DARE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DARE News
Atossa Therapeutics Receives FDA Orphan Drug Designation, Stock Rises Nearly 13%
Jan 20 2026
NASDAQ.COM
Daré Bioscience Launches DARE to PLAY™ Sildenafil Cream for Women, Effective in 10-15 Minutes
Dec 10 2025
Globenewswire
Daré Bioscience Launches DARE to PLAY™ Sildenafil Cream for Women, Effective in 10-15 Minutes
Dec 10 2025
Newsfilter
Daré Bioscience Regains Ovaprene® Rights, Advancing Women's Health Innovation
Dec 01 2025
Newsfilter
Daré Bioscience (DARE) Third Quarter 2025 Earnings Call Transcript
Nov 14 2025
NASDAQ.COM
Daré Bioscience Set to Receive Up to $300,000 for Global Assessment of Contraceptive Innovation Capabilities
Nov 03 2025
Newsfilter
Brinker International Analyst Becomes Optimistic; Check Out the Top 5 Upgrades for Thursday
Sep 04 2025
Benzinga
Daré Bioscience, Inc. (DARE) Q2 2025 Earnings Call Transcript
Aug 14 2025
Newsfilter
Daré Bioscience Posts Narrower Q2 Loss
Aug 14 2025
NASDAQ.COM
UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
Jul 21 2025
Newsfilter
3 Penny Stocks to Watch Now, 7/15/25
Jul 15 2025
TipRanks
US Stocks Close Mixed As Tariff Concerns Rise: Investor Sentiment Improves, Fear & Greed Index Remains In 'Extreme Greed' Zone
Jul 15 2025
Benzinga
Crude Oil Moves Lower; Daré Bioscience Shares Jump
Jul 14 2025
Benzinga
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Jul 14 2025
TipRanks
US Stocks Edge Lower; Fastenal Posts Upbeat Earnings
Jul 14 2025
Benzinga
Why Is Daré Bioscience Stock (DARE) Up 240% Today?
Jul 14 2025
TipRanks
Show More News
